Showing results (101-110 of 177) with videos related to
Sort By:
Pageof 18
The Journal of Urology|January 9, 2023
Pathological Effects of Apalutamide in Lower-risk Prostate Cancer: Results From a Phase II Clinical TrialMichael T Schweizer, Lawrence True, Roman Gulati, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 4, 2015
Androgen Receptor Modulation Optimized for Response (ARMOR) Phase I and II Studies: Galeterone for the Treatment of Castration-Resistant Prostate CancerBruce Montgomery, Mario A Eisenberger, Matthew B Rettig, et al.The Journal of Steroid Biochemistry and Molecular Biology|July 16, 2013
Development, validation and application of a stable isotope dilution liquid chromatography electrospray ionization/selected reaction monitoring/mass spectrometry (SID-LC/ESI/SRM/MS) method for quantification of keto-androgens in human serumDaniel Tamae, Michael Byrns, Brett Marck, et al.Chest|November 29, 2016
A Randomized Trial of the Amikacin Fosfomycin Inhalation System for the Adjunctive Therapy of Gram-Negative Ventilator-Associated Pneumonia: IASIS TrialMarin H Kollef, Jean-Damien Ricard, Damien Roux, et al.Oncotarget|October 11, 2014
Characterization of single disseminated prostate cancer cells reveals tumor cell heterogeneity and identifies dormancy associated pathwaysLisly Chéry, Hung-Ming Lam, Ilsa Coleman, et al.Plos One|October 31, 2014
Prostate cancer characteristics associated with response to pre-receptor targeting of the androgen axisElahe A Mostaghel, Andrew Morgan, Xiaotun Zhang, et al.The European Respiratory Journal|April 23, 2015
A new era in idiopathic pulmonary fibrosis: considerations for future clinical trialsHarold R Collard, Williamson Z Bradford, Vincent Cottin, et al.The Journal of Clinical Investigation|June 2, 2020
Taxane resistance in prostate cancer is mediated by decreased drug-target engagementAda Gjyrezi, Fang Xie, Olga Voznesensky, et al.Cell Reports|May 28, 2020
Combined TP53 and RB1 Loss Promotes Prostate Cancer Resistance to a Spectrum of Therapeutics and Confers Vulnerability to Replication StressMichael D Nyquist, Alexandra Corella, Ilsa Coleman, et al.JCO Precision Oncology|January 9, 2023
Internet-Based Germline Genetic Testing for Men With Metastatic Prostate CancerHeather H Cheng, Alexandra O Sokolova, Roman Gulati, et al.Pageof 18